Imaging Depression in Parkinson's Disease
Phase 2
120
about 4.1 years
40–80
1 site in CT
What this study is about
Researchers are testing whether imaging can help identify the brain areas that cause depression in people with Parkinson's disease. The trial will use scans to look at how different parts of the brain are working when people experience depression. It involves adults aged 40-80 experiencing symptoms of depression.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive 11C-UCB-J
- 2.Take ketamine hydrochloride
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Anesthetics (Dopamine Agonists)
Primary: Montgomery-Åsberg Depression Rating Scale (MADRS)
Neurology, Psychiatry / Mental Health